Galaxy MedicareNSE:GML +4.44%19 PB Ratio is 0.71 as of Jul. 12, 2026, which is 39% below its 10-year median of 1.16. GuruFocus rates NSE:GML with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Galaxy Medicare ranks better than 88.07% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-12), Galaxy Medicare's share price is ₹18.80. Galaxy Medicare's Book Value per Share for the quarter that ended in Mar. 2026 was ₹26.54. Hence, Galaxy Medicare's PB Ratio of today is 0.71.
Good Sign:
Galaxy Medicare Ltd stock PB Ratio (=0.71) is close to 1-year low of 0.65.
The historical rank and industry rank for Galaxy Medicare's PB Ratio or its related term are showing as below:
NSE:GML'
s PB Ratio Range Over the Past 10 Years
Min: 0.65 Med: 1.16 Max: 2.91
Current: 0.71
During the past 5 years, Galaxy Medicare's highest PB Ratio was 2.91. The lowest was 0.65. And the median was 1.16.
NSE:GML's PB Ratio is ranked better than 88.07% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.065
vs NSE:GML: 0.71
During the past 12 months, Galaxy Medicare's average Book Value Per Share Growth Rate was 66.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 31.20% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Galaxy Medicare was 31.20% per year. The lowest was 13.80% per year. And the median was 22.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Galaxy Medicare PB Ratio Related Terms
Galaxy Medicare PB Ratio Historical Data
* Premium members only.
The historical data trend for Galaxy Medicare's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Galaxy Medicare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galaxy Medicare PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Galaxy Medicare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Galaxy Medicare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Galaxy Medicare's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Galaxy Medicare (NSE:GML) has a PB Ratio of 0.71 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Galaxy Medicare and its competitors. This is 39% below median its historical median of 1.16. Over the past decade, Galaxy Medicare's PB Ratio has ranged from 0.65 to 2.91. According to the industry distribution chart, Galaxy Medicare ranks #94 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 11.9%.
Is Galaxy Medicare's PB Ratio too high?
Galaxy Medicare's current PB Ratio of 0.71 is 39% below median its 10-year median of 1.16. Over the past 10 years, this metric has ranged from a low of 0.65 to a high of 2.91. The Medical Devices & Instruments industry median PB Ratio is 2.07. Galaxy Medicare's value of 0.71 is 65.6% below this industry median. Based on the distribution chart, Galaxy Medicare ranks #94 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Galaxy Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Galaxy Medicare's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Galaxy Medicare ranks #94 out of 788 companies for PB Ratio. This places Galaxy Medicare in the top 12% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.07. Galaxy Medicare's value of 0.71 is 65.6% below this benchmark. Historically, Galaxy Medicare's own PB Ratio has ranged from 0.65 to 2.91 over the past decade. While the company's 10-year median is 1.16 vs. the industry median of 2.07, Galaxy Medicare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galaxy Medicare's current PB Ratio of 0.71 is 65.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Galaxy Medicare and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galaxy Medicare's current PB Ratio is 0.71, which is 39% below median its own 10-year median of 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galaxy Medicare stock overvalued right now?
Galaxy Medicare (NSE:GML) has a current PB Ratio of 0.71. The current PB Ratio is 0.71, which is 39% below median its 10-year median of 1.16 and 65.6% below the Medical Devices & Instruments industry median of 2.07. Galaxy Medicare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Galaxy Medicare (NSE:GML), the current PB Ratio is 0.71 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Galaxy Medicare Ltd is engaged into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompass: Manufacturing and Branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC.
19GF Score
Get the complete analysis for NSE:GML
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GML has been successfully added to your 